Cellular Basis for Regulation of Tumor Growth

  • Robert Evans
Part of the Contemporary Topics in Immunobiology book series (CTI, volume 10)


The association of host-derived cells with progressing transplantable tumors raises several important issues. For example, the relevance of the host cells to tumor growth is not clear, and the mechanisms that determine whether macrophages, lymphocytes, or granulocytes infiltrate the tumor mass are not understood. Similarly, it is not clear whether tumor-associated host cells (TAHC) play a role in therapy-induced regression, and to what extent manipulation of TAHC is possible either within the tumor or before they reach the tumor (see review by Evans, 1977c). Other questions arise from these, such as whether any influence that TAHC may appear to exert on tumor growth (induced regression or stimulation) is mediated directly, by soluble mediators or by acting in cooperation with other cell types. Moreover, while an effect may appear to occur locally, that is, progression or regression may be associated with the presence of particular cell types, the effect may actually be mediated from a distance, for example, by soluble mediators that originate at a distant site and circulate through the tumor and react directly with the neoplastic cells or with tumor-associated host effector cells. Dissection of the wide array of reactions that probably occur is obviously difficult and complex, but as a starting point it is a reasonable assumption that some of the answers may lie at the site of tumor growth, not necessarily to the exclusion of reactions occurring peripherally but perhaps in concert with them. This is not a comprehensive review and will cover only certain aspects of the cellular basis for regulation of tumor growth, having special reference to events occurring at the level of the tumor mass. Some experiments on the accumulation of host cells will be described, together with a discussion on the implications of such accumulation. The review will explore the possibility that tumor progression might be associated with cells able to enhance neoplastic cell proliferation directly, or indirectly by preventing cells generally associated with graft rejection from expressing cytotoxicity. Finally, the effects of drugs on the cellular composition of tumors during regression and regrowth following a period of remission will be discussed.


Neoplastic Cell Cellular Basis Irradiate Mouse Tumor Cell Implantation Whole Body Irradiation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Baum, M., and Fisher, B., 1972, Macrophage production by the bone marrow of tumor-bearing mice, Cancer Res. 32: 2813.PubMedGoogle Scholar
  2. Berendt, M. J., North, R. J., and Kirstein, D. P., 1978a, The immunological basis of endotoxin-induced tumor regression. Requirement for T-cell mediated immunity, J. Exp. Med. 148: 1550.PubMedCrossRefGoogle Scholar
  3. Berendt, M. J., North, R. J., and Kirstein, D. P., 1978b, The immunological basis of endotoxin-induced tumor regression. Requirement for a pre-existing state of concomitant anti-tumor immunity, J. Exp. Med. 148: 1560.PubMedCrossRefGoogle Scholar
  4. Brozna, J. P., and Ward, R. A., 1975. Antileukotactic properties of tumor cells, J. Clin. Invest. 56: 616.PubMedCrossRefGoogle Scholar
  5. Eccles, S. A., and Alexander, P., 1974, Macrophage content of tumors in relation to metastatic spread and host immune reactions, Nature (London) 250: 667.CrossRefGoogle Scholar
  6. Eccles, S. A., Bandlow, G., and Alexander, P., 1976, Monocytosis associated with growth of transplanted syngeneic sarcomas differing in immunogenicity, Br. J. Cancer 34:20.Google Scholar
  7. Evans, R., 1972, Macrophages in syngeneic animal tumors, Transplantation 14: 468.Google Scholar
  8. Evans, R., 1973, Macrophages and the tumor-bearing host, Br. J. Cancer 22 (i): 19.Google Scholar
  9. Evans, R., 1976, Tumor macrophages in host immunity to maligancies, in: The Macrophage in Neoplasia ( M. A. Fink, ed.), p. 27, Academic Press, New York.Google Scholar
  10. Evans, R., 1977a, The effect of X-irradiation on host cell infiltration and growth of a murine fibrosarcoma, Br. J. Cancer 35: 557.PubMedCrossRefGoogle Scholar
  11. Evans, R., 1977b, The effect of azathioprine on host cell infiltration and growth of a murine fibrosarcoma, Int. J. Cancer 20: 120.PubMedCrossRefGoogle Scholar
  12. Evans, R., 1977c, Macrophages in solid tumors, in: The Macrophage and Cancer ( K. James, B. McBride, and A. Stuart, eds.), p. 321, Econoprint, Edinburgh.Google Scholar
  13. Evans, R., 1978a, Macrophage requirement for growth of a murine fibrosarcoma, Br. J. Cancer 36: 1086.CrossRefGoogle Scholar
  14. Evans, R., 1978b, Failure to relate the anti-tumor action of cyclophosphamide with the immunogenicity of two murine fibrosarcomas, Int. J. Cancer 21: 611.PubMedCrossRefGoogle Scholar
  15. Evans, R., 1979, Host cells in transplanted murine tumors and their possible relevance to tumor growth, J. Reticuloendothel. Soc. 26: 427–437.PubMedGoogle Scholar
  16. Evans, R., and Alexander, P., 1976, Mechanisms of extracellular killing of nucleated mammalian cells by macrophages, in: Immunobiology of the Macrophage ( D. S. Nelson, ed.), p. 536, Academic Press, New York.Google Scholar
  17. Fauve, R. M., Hevin, B., Jacob, H., Guillard, J. A., and Jacob, F., 1974, Anti-inflammatory effects of murine malignant cells, Proc. Natl. Acad. Sci. USA 71: 4052.PubMedCrossRefGoogle Scholar
  18. Haskill, J. S., Yamamura, Y., and Radov, L. A., 1975, Host responses within solid tumors: Non-thymus derived specific cytotoxic cells within a murine mammary adenocarcinoma, Int. J. Cancer 16: 798.PubMedCrossRefGoogle Scholar
  19. Hibbard, A. D., and Metcalf, D., 1971, Proliferation of macrophage and granulocyte precursors in response to primary and transplanted tumors, Isr. J. Med. Sci. 7: 202.Google Scholar
  20. Holden, H. T., Haskill, J. S., Kirchner, H., and Herbermann, R. B., 1976, Two functionally distinct anti-tumor effector cells isolated from primary murine sarcoma virus-induced tumors, J. Immunol. 117: 440.PubMedGoogle Scholar
  21. Lappat, E. J., and Cawein, M., 1964, A study of the leukemoid response to transplantable A-280 tumor in mice, Cancer Res. 24: 302.PubMedGoogle Scholar
  22. Mantovani, A., 1979, Effects on in vitro tumor growth of murine macrophages isolated from sarcoma line differing in immunogenicity and metastasizing capacity, Int. J. Cancer 22: 741.CrossRefGoogle Scholar
  23. Mathé, G., Halle-Panneko, O., and Bourut, C., 1974, Immune manipulation by BCG administered before or after cyclophosphamide chemo-immunotherapy of L1210 leukemia, Eur. J. Cancer 10: 661.PubMedGoogle Scholar
  24. Meltzer, M. A., and Stevenson, M. M., 1977, Macrophage function in tumor-bearing mice: Tumoricidal and chemotactic responses of macrophages activated by infection with Mycobacterium bovis, strain BCG, J. Immunol. 118: 2176.PubMedGoogle Scholar
  25. Moore, M., and Williams, D. E., 1973, Contribution of host immunity to cyclophosphamide therapy of a chemically-induced murine fibrosarcoma, Int. J. Cancer 11:358.Google Scholar
  26. Normann, S. J., and Cornelius, J., 1978, Concurrent depression of tumor macrophage infil- tration and systemic inflammation by progressive cancer growth, Cancer Res. 38: 3453.PubMedGoogle Scholar
  27. Normann, S. J., Schardt, M., and Sorkin, E., 1977, Do tumors escape suveillance by depression of macrophage inflammation? in: The Macrophage and Cancer ( K. James, B. McBride, and A. Stuart, eds.), p. 247, Econoprint, Edinburgh.Google Scholar
  28. Prehn, R. T., 1977, Immunostimulation of the lymphodependent phase of neoplastic growth, J. Natl. Cancer Inst. 59: 1043.PubMedGoogle Scholar
  29. Radov, L. A., Haskill, J. S., and Korn, J. H., 1976, Host immune potentiation of drug responses to a murine mammary adenocarcinoma, Int. J. Cancer 17: 773.PubMedCrossRefGoogle Scholar
  30. Rhodes, J., Bishop, M., and Benfield, J., 1979, Tumor surveillance: How tumors may resist macrophage-mediated host defense, Science 203: 179.PubMedCrossRefGoogle Scholar
  31. Russell, S. W., Doe, W. F., and McIntosh, A. T., 1977a, A non-cytolytic stage of macrophage activation in Maloney sarcomas, in: The Macrophage and Cancer ( K. James, B. McBride, and A. Stuart, eds.), p. 341, Econoprint, Edinburgh.Google Scholar
  32. Russell, S. W., Gillespie, G. Y., and McIntosh, A. T., 1977b, Inflammatory cells in solid murine neoplasms. III. Cytotoxicity mediated in vitro by macrophages recovered from disaggregated regressing Maloney sarcomas, J. Immunol. 118: 1574.PubMedGoogle Scholar
  33. Salmon, S. W., and Hamburger, A. W., 1978, Immunoproliferation and cancer: A common macrophage-derived promoter, Lancet 1: 1289.PubMedCrossRefGoogle Scholar
  34. Snyderman, R., and Pike, M. C., 1976, Defective macrophage migration produced by neo-plasms: Identification of an inhibitor of macrophage chemotaxis, in: The Macrophage in Neoplasia ( M. A. Fink, ed.), p. 49, Academic Press, New York.Google Scholar
  35. Steele, G., and Pierce, G. E., 1974, Effects of cyclophosphamide on immunity against chemically induced syngeneic murine fibrosarcomas, Int. J. Cancer 13: 572.PubMedCrossRefGoogle Scholar
  36. Szymaniec, S., and James, K., 1976, Studies on the Fc receptor bearing cells in a transplanted methylcholanthrene induced mouse fibrosarcoma, Br. J. Cancer 33: 36.PubMedCrossRefGoogle Scholar
  37. Ziegler, J. L., Morrow, R. H., Fass, L., Kyalwali, S. K., and Carbone, P. P., 1970, Treatment of Burkitt’s tumor with cyclophosphamide, Cancer 26:474.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1980

Authors and Affiliations

  • Robert Evans
    • 1
  1. 1.The Jackson LaboratoryBar HarborUSA

Personalised recommendations